It should be recognised that the concept of clinical benefit for in vitro diagnostic medical devices is fundamentally different from that which applies in the case of pharmaceuticals or of therapeutic medical devices, since the benefit of in vitro diagnostic medical devices lies in providing accurate medical information on patients, where appropriate, assessed against medical information obtained through the use of other diagnostic options and technologies, whereas the final clinical outcome for the patient is dependent on further diagnostic and/or therapeutic options which could be available.
Ba cheart a aithint gur coincheap iomlán difriúil é coincheap na sochar cliniciúil maidir le feistí leighis diagnóiseacha in vitro ó choincheap na sochar cliniciúil atá infheidhme maidir le cógais nó feistí leighis teiripeacha toisc go mbaineann an sochar a bhaintear as feistí leighis diagnóiseacha in vitro le faisnéis leighis chruinn a thabhairt maidir le hothair, agus í á meas i gcomparáid le faisnéis leighis a fuarthas trí roghanna agus teicneolaíochtaí diagnóiseacha eile a úsáid nuair is iomchuí, fad is go bhfuil an toradh cliniciúil deiridh don othar ag brath ar roghanna breise diagnóiseacha agus/nó teiripeacha a d'fhéadfadh a bheith ar fáil.